Bayer Raises 2026 Profit Outlook as Pharma Beats Expectations
Bayer raised its 2026 profit outlook, citing stronger-than-expected performance in its pharmaceuticals business.
Bayer raised its 2026 profit outlook, citing stronger-than-expected performance in its pharmaceuticals business.